Treatment with HDAC inhibitor of ovarian cancer TP53 GOF mutant cell lines lead to potential dissociation of GOF p53–Hsp 90 complex, thereby leading to mutant p53 degradation. This evidence concerns the gene TP53 and ovarian carcinoma.